INTERNATIONAL PATENT: CARMOT THERAPEUTICS INC. FILES APPLICATION FOR "METHOD OF TREATING DIABETES USING A GLP-1 RECEPTOR AGONIST"

GENEVA, Dec. 24 -- CARMOT THERAPEUTICS INC. (1 DNA WaySouth San Francisco, California 94080) filed a patent application (PCT/US2025/033371) for "METHOD OF TREATING DIABETES USING A GLP-1 RECEPTOR AGONIST" on Jun 12, 2025. With publication no. WO/2025/259888, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHAKRAVARTHY, Manu (c/o Carmot Therapeutics, Inc.1 DNA WaySouth San Francisco, California 94080), ELLIOTT, Michael (2609 Happy Tails TrailWake Forest, North Carolina 27587), WU, Jingtao (c/o Carmot Therapeutics, Inc.1 DN...